TAIWAN: LIFE-CYCLE INSIGHTS 

GettyImages-1129861757.jpg

IPD’s Taiwanese subscription brings local expertise to this unique market, offering:

  • Easy-to-use Taiwanese brand, biosimilar,

       and generic drug launch 

       tracking schedules
 

  • Taiwanese litigation, invalidation, and
    patent-term extension dispute tracking
    alongside 
    courtroom coverage and 
    real-time email updates

  • ƒPersonalized consults with local Taiwanese intellectual property analysts 
     

  • ƒWeekly updates including trending Taiwanese drug topics, recent publications,
    and loss-of-exclusivity information

     

  • Complete drug information with locally reviewed Taiwanese indications
     

  • Comprehensive Taiwanese clinical development tracking in every major disease class
     

  • Taiwanese API (DMF) information

Taiwan.png